Literature DB >> 11409659

COX-2 inhibition: an advance or only pharmaceutical "hype"?

L S Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11409659     DOI： 10.1002/1529-0131(200106)45:3<209::AID-ART250>3.0.CO;2-A

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  2 in total

1.  Synthesis of tert-butyl (substituted benzamido)phenylcarbamate derivatives: anti-inflammatory activity and docking studies.

Authors:  Shankar Bhookya; Jalapathi Pochampally; Anil Valeru; Vianala Sunitha; Saikrishna Balabadra; Vijjulatha Manga; Karunakar Rao Kudle
Journal:  J Chem Biol       Date:  2017-04-05

Review 2.  Erosive osteoarthritis: presentation, clinical pearls, and therapy.

Authors:  G E Ehrlich
Journal:  Curr Rheumatol Rep       Date:  2001-12       Impact factor: 4.686
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.